French biotechnology company MedDay on Friday announced encouraging results for a multiple sclerosis (MS) drug trial, saying it decreased its progress and in some cases led to a "significant improvement" for sufferers.
from Zee News :Zee News - Health http://bit.ly/1HBw7Mo via Health News Daily
No comments:
Post a Comment